脑部放疗，上午比下午敏感许多！
1 `! A. a) |- R( j
, ^6 ~( Z! C9 [+ s
5 L/ q \" L |- kCancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9., g; O9 |0 p3 ?1 u& [+ y1 w
Gamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?4 q3 ^* f* z( k' o T+ l2 o
Rahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.' J# B! W2 |: ~; V* [
SourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.! U0 h8 r6 E8 ~& c$ c% Q
* f' }/ z2 z5 M4 m7 R" l
Abstract
! H' H( ?! h; N$ J9 yBACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.- J9 e9 w& S/ J" m5 F9 E4 P
4 u0 ~8 G5 y X3 I! i
METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic." L N- P+ [$ \, J( @5 A- j0 p
" g4 R5 T: M5 U" D
RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).
& ?1 R1 F( `& r4 T$ h+ i+ |0 M/ O% p/ D$ h7 A2 J
CONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.8 [$ I. a: E/ j. z7 T8 X5 B, d
5 a/ d: o' M" e( e- ?. p! q' S |
8 p% x! e: j5 ~( {
显身卡
